AMFI Registered ARN-284122
Certified Mutual Fund Advisory

Need Professional Guidance on Your Mutual Funds & SIPs?

Get a 100% free, unbiased portfolio health check and personalized roadmap from certified advisors — zero sales pressure.

MUTUAL FUNDS⏱️ 3 min readPublished July 3, 2026

Why Everyone's Suddenly Obsessed with Lenskart and Whether You Should Be Too

VB
Vikrant Bhardwaj
AMFI ARN-284122 • NISM Series V-A Certified
Follow on Google News
Stock market ticker board showing eyewear company share price movement
MUTUAL FUNDS⏱️ 3 min read

Executive Summary & Key Takeaways

E-E-A-T Verified • Fact-Checked by AMFI ARN-284122

⚡ Direct Fast Answer:Lenskart's IPO was one of 2025's most talked-about listings — oversubscribed, star-studded anchor list, and a debut that didn't quite live up to the hype. Here's what actually happened and what it teaches everyday investors.
  • Authored and reviewed by AMFI-registered mutual fund distributor Vikrant Bhardwaj (ARN-284122).
  • Fact-checked against official SEBI master circulars and AMFI industry data.
  • Zero commercial sponsor bias — objective, goal-first financial analysis.
  • Optimized for citation across Google Discover, AI Overviews, and financial research.

Why Everyone's Suddenly Obsessed with Lenskart and Whether You Should Be Too

If you were anywhere near financial Twitter, Instagram, or your family's WhatsApp group in early November 2025, you couldn't avoid Lenskart. India's largest eyewear retailer by volume launched a ₹7,278 crore IPO, drew anchor investment from Goldman Sachs, JP Morgan, BlackRock, and the Government of Singapore, and became one of the most debated listings of the year. So what actually happened — and more importantly, what should you take away from it?

The Numbers Behind the Hype

Lenskart priced its IPO between ₹382–₹402 per share, raising money through a mix of fresh issue and offer for sale. The company reported revenue of over ₹7,000 crore for FY25, up more than 22% year-on-year, and posted a profit after a loss the previous year. With over 2,700 stores across India and international markets, and more than 100 million app downloads, the brand recognition was undeniable.

But brand recognition and stock valuation are two very different things. At the upper price band, Lenskart was valued at roughly 235 times its FY25 earnings — a multiple far higher than even its global peer EssilorLuxottica, which trades closer to 50 times earnings.

Person trying on eyeglasses at an optical store

What Happened on Listing Day

Despite an oversubscribed book, Lenskart's debut on the NSE and BSE was underwhelming — shares listed close to the issue price rather than delivering the pop many retail investors had hoped for. This is a pattern SEBI itself has flagged: its research shows over half of retail IPO allottees sell their shares within a week of listing, often chasing the next hot IPO instead of holding for the long term.

The Real Lesson for Investors

This isn't really a story about whether Lenskart is a good or bad company — by most accounts, it's a strong, category-leading business. The real story is about how retail investors approach IPOs:

  • A well-known brand doesn't automatically mean a well-priced stock.
  • A high subscription number reflects demand, not value — valuation and fundamentals matter more.
  • Chasing listing-day gains is a short-term trading strategy, not investing, and it comes with real risk of loss.

Investor analysing stock charts and financial data on a laptop

So, Should You Be "Obsessed" With It?

If you already hold Lenskart shares, the question isn't whether the hype was justified — it's whether the business can grow into its valuation over the next 3–5 years through store expansion, international growth, and margin improvement. If you don't hold it, there's no urgency to chase it just because everyone else is talking about it.

New-age IPOs like Lenskart are best evaluated the same way you'd evaluate any stock or fund: business quality, valuation, and how it fits your overall portfolio — not social media buzz.

Not sure how a stock like this fits into your existing portfolio? Get in touch with Stockstrail for a personalised review.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Stock market investments are subject to market risks. Please consult a qualified advisor before investing.

Stockstrail Advisory• AMFI ARN-284122

Need Expert Review on Your Existing Mutual Funds or SIPs?

Get an unbiased, data-backed portfolio health check from Stockstrail's NISM certified mutual fund advisors. 100% Free.

Was this guide helpful to your financial planning?

Help us improve our editorial research and investment analysis

Need Certified Guidance on Your Mutual Funds Portfolio?

Stockstrail is an AMFI-Registered Mutual Fund Distributor (ARN-284122). Take our free 2-minute risk assessment or speak directly with our certified advisors.

Editorial Integrity & Fact-Check Standard
SEBI Compliant • E-E-A-T Verified

All research and regulatory interpretations published by Stockstrail are authored and reviewed by AMFI-registered mutual fund distributor Vikrant Bhardwaj (ARN-284122). Content is independently prepared with zero sponsor bias and formatted for transparent citation across Google Discover, AI Overviews, and financial researchers.

The Stockstrail Dispatch • Free Weekly Edition

Smart Investing, Delivered Every Saturday

Receive clear, jargon-free breakdowns on mutual funds, SEBI regulatory changes, and disciplined portfolio building strategies straight to your inbox.

No spam ever. 100% Free. Unsubscribe anytime.
Continue Reading

Related Financial Insights

View all articles
Free Interactive Wealth Simulator

Plan Your Financial Goals with Certified Precision

Simulate your ₹10,000/month SIP growth, calculate compounding interest on FDs, or model your retirement corpus in 1 click.